Can an Infection Cause High Triglycerides?

Infections can and frequently do raise triglyceride levels. When bacteria, viruses, or parasites invade the body, the immune system triggers a cascade of changes in fat metabolism that often sends triglycerides climbing. This is not a side effect or a fluke on a blood test. Research over the past several decades has established that the liver ramps up its production of triglyceride-rich lipoproteins as part of the body’s defense against invading pathogens, and infections simultaneously slow down the enzymes that clear those fats from the bloodstream. The result is a measurable, sometimes dramatic, spike in circulating triglycerides.

How Infections Push Triglycerides Up

The mechanism works through two main channels that operate at the same time. First, during an infection, immune cells release signaling molecules called cytokines. These cytokines instruct the liver to increase its production and secretion of triglyceride-rich lipoproteins, especially very-low-density lipoproteins (VLDL). Second, the same immune signals suppress lipoprotein lipase, the enzyme that normally breaks down triglycerides so tissues can absorb fatty acids for energy. With production going up and clearance going down, triglycerides accumulate in the blood.¹

At the same time, fat tissue itself gets recruited into the response. When the immune system detects a pathogen, natural killer cells in fat tissue release a signaling molecule that shifts fat cells from storing lipids to releasing them. This floods the circulation with free fatty acids, which the liver can then repackage into more triglyceride-rich particles.² The process feeds itself: more raw material arriving at the liver means more triglyceride output. In septic patients, researchers have confirmed that subcutaneous fat tissue ramps up the breakdown of stored fat, releasing glycerol and fatty acids at rates higher than in healthy people.³

Bacterial Infections and Endotoxin

The strongest and most studied connection between infection and high triglycerides involves gram-negative bacteria. These bacteria have a component in their outer wall called lipopolysaccharide (LPS), commonly known as endotoxin. Even tiny amounts of LPS entering the bloodstream can trigger a rapid rise in triglycerides. In rodent experiments, doses of endotoxin far too small to cause shock or death still produced a roughly 78 percent increase in serum triglycerides within just two hours.⁴ At low doses, the main effect was increased liver triglyceride production. At high doses, the clearance machinery shut down too, compounding the rise.

The response is not a brief blip. When researchers gave rats sustained low-level exposure to LPS, mimicking a chronic or smoldering infection, triglyceride levels stayed elevated for the entire two-week observation period.⁵ This matters because it shows that ongoing, low-grade bacterial exposure, not just overwhelming sepsis, can keep triglycerides elevated.

In clinical gram-negative sepsis, the lipid picture involves more than just triglycerides going up. Certain bacterial toxins, such as pyocyanin from Pseudomonas aeruginosa, damage the specialized cells lining liver blood vessels, which can further disrupt how the liver handles lipids. The combined effect of lipoprotein lipase suppression and increased liver triglyceride output is a hallmark of gram-negative bloodstream infections.⁶

Viral Infections and Lipid Disruption

Viruses disrupt lipid metabolism too, but the patterns are more varied than with bacteria. Some viruses raise triglycerides through the same inflammatory pathways, while others hijack the body’s fat-handling machinery in virus-specific ways.

HIV is one of the clearest examples. Even before antiretroviral treatment enters the picture, untreated HIV infection tends to raise triglycerides while driving down HDL cholesterol and total cholesterol. The effect gets worse as the disease advances, and higher levels of circulating virus correlate with more severe lipid abnormalities.⁷ Antiretroviral drugs, especially older protease inhibitors, can pile additional triglyceride effects on top of what the virus itself does, making it hard for patients and clinicians to untangle the contributions.

Hepatitis C takes a different approach. Rather than simply triggering an inflammatory lipid surge, the hepatitis C virus depends on the body’s lipid machinery for its own life cycle. The virus’s core protein causes fat to accumulate inside liver cells, a condition called steatosis.⁸ At the same time, hepatitis C appears to interfere with the assembly of VLDL particles, reducing the export of fat from the liver into the bloodstream. The result is often lower blood cholesterol rather than higher triglycerides, which is the opposite of the typical infection pattern.⁹ Hepatitis C serves as a good reminder that “infection raises triglycerides” is a general rule with real exceptions.

COVID-19 added another complicated chapter. A retrospective study comparing hospitalized COVID patients to controls found that triglycerides, along with most other lipid measures, were actually lower in COVID patients. The decline got steeper as disease severity increased: median triglycerides went from about 186 mg/dL in mild cases to roughly 111 mg/dL in critical cases.¹⁰ Yet other research found that among patients with severe COVID, those who died had higher triglycerides than those who survived.¹¹ These findings are not necessarily contradictory: the overall trend in severe illness may be for lipids to drop as the body’s resources are consumed, but a subset of patients with a more exaggerated inflammatory lipid response may fare worse. The takeaway is that lipid changes during any given infection depend on the specific pathogen, the severity of disease, and the patient’s baseline metabolism.

Chronic and Low-Grade Infections

You do not need a dramatic, life-threatening infection to see triglycerides nudge upward. Periodontal disease, the chronic infection of the gums that affects a huge proportion of adults worldwide, has a well-documented association with elevated triglycerides. A large systematic review pooling data from 17 studies found that people with periodontitis had about 58 percent higher odds of elevated triglycerides compared to those without gum disease.¹² Higher triglyceride levels were also observed directly in patients with periodontitis compared to healthy controls.¹³

The relationship appears to be bidirectional: gum disease drives lipid changes, and abnormal lipids may worsen gum disease. Encouragingly, treating the gum infection helps. A randomized controlled trial of patients with both high lipids and chronic periodontitis found that intensive periodontal treatment improved serum lipid levels and lowered inflammatory markers.¹⁴ If you have persistently high triglycerides and your dentist has been urging you to address gum disease, this is one more reason to follow through.

Parasitic infections can alter lipid profiles too. A review of the literature on cholesterol and parasites found that active infections with a range of parasites produced significant changes in lipid levels, both in patients and in experimental models.¹⁵ The direction and magnitude depend on the specific parasite, the organ it infects, and the host’s immune response, but the general principle holds: the immune system’s reaction to a foreign invader reshuffles how the body handles fats.

Why the Body Raises Triglycerides on Purpose

The triglyceride surge during infection is not metabolic collateral damage. It appears to be a deliberate and ancient immune strategy. Triglyceride-rich lipoproteins, particularly VLDL and chylomicrons, can bind and neutralize bacterial endotoxin. By flooding the bloodstream with these particles, the body essentially deploys a lipid sponge that soaks up toxic bacterial products before they can trigger organ damage.¹⁶ The lipoproteins redirect the captured toxins to the liver for disposal, reducing the toxin’s ability to activate a dangerous systemic inflammatory response.

This defense is part of the innate immune system, the fast-acting, nonspecific arm of immunity that every animal shares. Researchers have argued that the characteristic lipid pattern seen in infections, rising triglycerides paired with falling HDL cholesterol, is an evolutionarily conserved response aimed at redistributing nutrients to immune cells and neutralizing harmful substances. The drop in HDL may itself help trigger the compensatory rise in VLDL, since the body senses the need for more phospholipid-rich particles capable of binding toxins.¹⁷ Cytokines further reinforce this shift by reprogramming the liver’s lipid output during illness.¹⁸

This protective role complicates the usual framing of high triglycerides as inherently bad. In the setting of chronic metabolic disease, elevated triglycerides track with heart disease risk. During an acute infection, the same elevation may be the body doing exactly what it should. The context matters enormously when interpreting a triglyceride number on a lab report.

When High Triglycerides During Infection Signal Danger

Although the triglyceride response is protective up to a point, extreme elevations during severe infections are associated with worse outcomes. In ICU patients with sepsis, a higher ratio of triglycerides to HDL cholesterol independently predicted a higher risk of dying within 28 days. Patients in the highest quarter of this ratio had roughly two to four times the mortality risk compared to those in the lowest quarter, depending on the statistical model used.¹⁹ Similarly, composite metabolic markers incorporating triglycerides were substantially higher in sepsis patients who did not survive, pointing to more severe metabolic stress in those with the worst outcomes.²⁰

One particularly striking example is hemophagocytic lymphohistiocytosis (HLH), a life-threatening inflammatory syndrome that can be triggered by severe infections. High triglycerides are one of the diagnostic criteria for HLH. In a study of 28 patients with secondary HLH, about two-thirds had hypertriglyceridemia at some point during their illness, with mean triglyceride levels around 242 mg/dL. As patients responded to treatment, their triglycerides fell dramatically, from an average of roughly 297 mg/dL before treatment to about 136 mg/dL afterward.²¹ In HLH, the triglyceride level serves as both a diagnostic clue and a rough measure of how well treatment is working.

What Happens to Other Lab Results

If an infection has pushed your triglycerides high enough, it can distort other blood tests in ways that confuse clinicians. The most well-known artifact is pseudohyponatremia: a falsely low sodium reading caused by the physical displacement of water in the blood sample. When triglyceride and cholesterol levels are very high, the lipid particles take up space in the serum that would normally be occupied by water. Older lab techniques that measure sodium concentration in the total serum volume then report a sodium level that looks dangerously low, even though the actual sodium concentration in the water portion of your blood is perfectly normal.²² Newer direct ion-selective electrode methods avoid this problem, but not every lab uses them. If you are being treated for a serious infection and a sodium result comes back unexpectedly low, your doctor should check whether severe lipemia might be skewing the number before starting aggressive sodium correction.

Lipemic serum, the milky-looking blood sample that results from very high triglycerides, can also interfere with measurements of hemoglobin, bilirubin, and certain other analytes. Labs typically flag these samples and may ask for a redraw or use alternative techniques, but it is worth being aware that sky-high triglycerides during an infection can create a cascade of confusing lab numbers beyond the lipid panel itself.

How Quickly Triglycerides Normalize After an Infection

In most cases, the triglyceride elevation that accompanies an acute infection resolves as the infection clears. Research tracking lipid levels through the course of sepsis has found that serum lipids return toward normal concentrations in parallel with clinical recovery.²³ For a straightforward bacterial infection treated with antibiotics, triglycerides typically settle within days to a few weeks. There is no standard timeline that applies to every patient, since the speed of normalization depends on how severe the infection was, what other metabolic conditions the patient has, and whether the underlying cause has been fully treated.

Chronic infections are a different story. If the infection persists, so do the lipid abnormalities. An untreated HIV infection will keep triglycerides elevated for years. Chronic periodontal disease maintains a low-grade inflammatory signal that nudges lipids in an unfavorable direction month after month. In these cases, addressing the infection itself is the most effective route to normalizing triglycerides, though lipid-lowering medications may be needed alongside if cardiovascular risk is high.

Pediatric and Age-Related Differences

Most of the research on infection-related triglyceride changes comes from adult populations, and there is reason to think children may respond differently. Lipid metabolism in children is not simply a scaled-down version of adult metabolism: baseline lipid levels, immune maturation, and body composition all differ. Some researchers have noted that the lipid profile changes during infection in pediatric patients may follow different patterns than those observed in adults.²⁴ This is an area where the evidence is still thin, but it matters practically: a pediatrician interpreting a high triglyceride result during a child’s illness should not automatically apply the same benchmarks or expectations drawn from adult sepsis studies.

At the other end of the age spectrum, older adults often have higher baseline triglycerides due to metabolic changes, medications, and co-existing conditions like diabetes or obesity. An infection-driven spike layered on top of already borderline levels can push triglycerides into a range that increases the risk of pancreatitis, a serious complication of very high triglycerides regardless of the cause. For older patients or anyone with pre-existing lipid abnormalities, clinicians may need to monitor triglycerides more closely during severe infections to prevent this complication.

Practical Takeaways for Interpreting a Blood Test

If you had blood drawn while fighting a cold, recovering from a stomach bug, or dealing with a dental abscess, and your triglyceride number came back higher than expected, the infection is a plausible explanation. Routine lipid panels are most reliable when drawn during a period of stable health. Most clinical guidelines already recommend fasting before a lipid panel, but few explicitly warn patients to avoid testing during or immediately after an illness, even though the evidence clearly shows infections can skew results.

This does not mean you should ignore a high triglyceride reading just because you were recently sick. If the number is very high, above roughly 500 mg/dL, it warrants attention regardless of the cause because of the pancreatitis risk. And if repeat testing after recovery still shows elevated triglycerides, the infection was probably not the whole story. The practical move is straightforward: note the illness, recheck your lipids a few weeks after you have fully recovered, and use that second result as your baseline for any treatment decisions. If a chronic infection like periodontitis or HIV is in the picture, treating the infection is an essential part of managing the lipid problem rather than just reaching for a statin or fibrate.